Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation
- PMID: 17869449
- DOI: 10.1016/j.ijrobp.2007.06.037
Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation
Abstract
Purpose: To retrospectively evaluate the efficacy of total lymphoid irradiation (TLI)-based reconditioning regimens in patients with graft failure or graft rejection after allogeneic hematopoietic stem cell transplantation.
Methods and materials: The results of 14 patients (7 adults and 7 children) with a variety of hematologic malignant diseases treated with a TLI-based reconditioning regimen with 7-Gy single-dose application plus anti-T-lymphocyte antibody OKT3 (n = 11) and/or antithymocyte globulin (n = 7)/fludarabine (n = 9), followed by an infusion of peripheral blood stem cells (n = 13) or bone marrow stem cells (n = 1) from related or unrelated donors, were retrospectively analyzed.
Results: Of the 14 recipients, the data from 11 were evaluable for engraftment after TLI-based reconditioning because 3 adults died early (at Day 2, 5, and 15) after the second transplantation of infectious complications. Engraftment in 4 adults was seen after a median of 12 days (range, 10-18) and occurred after a median of 10 days (range, 9-32) in the 7 children. TLI-based reconditioning was well-tolerated with no severe toxicity. The median overall survival and disease-free survival for the whole cohort was 140 days (range, 5-1,268). After a median follow-up of 681 days, the disease-free survival and overall survival rate was 85.7% and 85.7%, respectively, in the children. Despite engraftment in the 4 remaining adults, 1 died of fatal graft-vs.-host disease, 1 of infectious complications, 1 of disease relapse, and 1 of acute respiratory distress syndrome.
Conclusions: In patients with graft failure or graft rejection after allogeneic hematopoietic stem cell transplantation, TLI-based reconditioning regimens allow sustained engraftment, paralleled by a favorable toxicity profile, potentially leading to long-term survival.
Similar articles
-
Immunosuppressive Total Nodal Irradiation-Based Reconditioning Regimens After Graft Rejection or Graft Failure in Pediatric Patients Treated With Myeloablative Allogeneic Hematopoietic Cell Transplantation.Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):137-143. doi: 10.1016/j.ijrobp.2018.12.031. Epub 2018 Dec 26. Int J Radiat Oncol Biol Phys. 2019. PMID: 30593907
-
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.Blood Cells Mol Dis. 2008 Jan-Feb;40(1):13-9. doi: 10.1016/j.bcmd.2007.07.001. Epub 2007 Sep 14. Blood Cells Mol Dis. 2008. PMID: 17869547 Clinical Trial.
-
Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. doi: 10.1016/j.bcmd.2007.06.019. Epub 2007 Sep 10. Blood Cells Mol Dis. 2008. PMID: 17827036 Review.
-
Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.Biol Blood Marrow Transplant. 2007 Jul;13(7):790-805. doi: 10.1016/j.bbmt.2007.03.002. Epub 2007 Apr 23. Biol Blood Marrow Transplant. 2007. PMID: 17580257
-
The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.Semin Hematol. 2006 Apr;43(2 Suppl 2):S35-43. doi: 10.1053/j.seminhematol.2005.12.007. Semin Hematol. 2006. PMID: 16549113 Review.
Cited by
-
Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients.Br J Haematol. 2016 Oct;175(1):115-22. doi: 10.1111/bjh.14190. Epub 2016 Jun 24. Br J Haematol. 2016. PMID: 27341180 Free PMC article.
-
T lymphocytes and normal tissue responses to radiation.Front Oncol. 2012 Sep 19;2:119. doi: 10.3389/fonc.2012.00119. eCollection 2012. Front Oncol. 2012. PMID: 23050243 Free PMC article.
-
Dual in vivo T cell depleted haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and anti-thymocyte globulin as a third salvage transplant for leukocyte adhesion deficiency with graft failure: a case report.Front Immunol. 2025 Jan 8;15:1475448. doi: 10.3389/fimmu.2024.1475448. eCollection 2024. Front Immunol. 2025. PMID: 39845947 Free PMC article.
-
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.Biol Blood Marrow Transplant. 2009 Oct;15(10):1314-22. doi: 10.1016/j.bbmt.2009.06.011. Epub 2009 Aug 3. Biol Blood Marrow Transplant. 2009. PMID: 19747640 Free PMC article.
-
Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies.J Cancer Res Clin Oncol. 2017 May;143(5):759-771. doi: 10.1007/s00432-017-2348-z. Epub 2017 Feb 16. J Cancer Res Clin Oncol. 2017. PMID: 28210842 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources